Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Hematologic Malignancies

Machine Learning based Classifier for lytic bone lesions of Langerhans cell histocytosis (LCH) and multiple myeloma (MM).

Rakesh Kumar, Anil Pandey, Sumit Garg, Aditi Khurana and Rachna Seth
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P1061;
Rakesh Kumar
1All India Institute of Medical Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil Pandey
2All India Institute of Medical Sciences
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sumit Garg
3All India Institute of Medical Sciences, New Delhi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aditi Khurana
4All India Institute of Medical Sciences, New Delhi , India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachna Seth
1All India Institute of Medical Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

P1061

Introduction: Langerhans cell histocytosis (LCH) and multiple myeloma (MM) commonly present with lytic bone lesions. These lesions can be differentiated based on clinical history and histopathology. However, radiologically, there is significant overlap in the finding of these two conditions on F18-FDG-PET/CT. The present study was aimed to find out role of Machine Learning based Classifier to differentiate lytic bone lesions of LCH and MM.

Methods: The trans-axial F18-FDG-PET/CT image of histopathologically proven patients of LCH (n=77) and Multiple Myeloma (n=85). The lesion was segmented and texture of the lesion {26 Haralick texture features (13 at 1 pixel, and another 13 at 2-pixel distance)} were computed. Oversampling method was used to balance the dataset and then features having correlation greater than 0.70 were dropped. The remaining four feature vectors were used for training and testing the machine learning model (SVMradial) for classifying the LCH and Multiple myeloma images. The following procedures were repeated fifty times: "random partition of dataset into training and test dataset in the ratio of 70:30, 10-fold cross validation techniques during training, testing the performance of the trained model on test dataset". The model having best performance was selected. All experiments were performed on personal computer in R using the "ROSE" and "CARET" package.

Results: Of 77 LCH patients (mean age = 7.89 ± 9.76 years; median age = 4 years, mode = 2 years, range = 0.5 years to 47 years), 25 patients were female and 52 patients were male. Of 85 Multiple Myeloma patients (mean age = 51.83 ± 9.65 years; range: 31 years to 81 years) 50 patients were male and 35 patients were female. The best performing model (SVMradial) was found to have 89% accuracy, 92% sensitivity and 85% specificity on training dataset. When machine learning SVMradial model was applied on test data set in classifying the lytic lesions of LCH and multiple Myeloma, it was found to have accuracy of 80%, sensitivity of 72%, and specificity of 88%.

Conclusions: The trained machine learning model, SVMradial classifier, was found to differentiate lytic bone lesions of Langerhans cell histocytosis (LCH) and Multiple myeloma with high specificity and accuracy.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Machine Learning based Classifier for lytic bone lesions of Langerhans cell histocytosis (LCH) and multiple myeloma (MM).
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Machine Learning based Classifier for lytic bone lesions of Langerhans cell histocytosis (LCH) and multiple myeloma (MM).
Rakesh Kumar, Anil Pandey, Sumit Garg, Aditi Khurana, Rachna Seth
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1061;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Machine Learning based Classifier for lytic bone lesions of Langerhans cell histocytosis (LCH) and multiple myeloma (MM).
Rakesh Kumar, Anil Pandey, Sumit Garg, Aditi Khurana, Rachna Seth
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1061;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Prognostic value of very early interim FDG PET/CT after single cycle of chemotherapy for 10-year survival in diffuse large B-cell lymphoma
  • Performance of [18F]-FDG PET/CT-derived Semi-Quantitative Parameters in Primary Tumor Staging of Mycosis Fungoides
  • The Role of Quantitative PET parameters in the identification of non-responsive patients with relapsed/refractory large B-cell Lymphoma treated with chimeric antigen receptor T-cell therapy.
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Hematologic Malignancies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire